Posizioni attive di Andrew Muratore
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Direttore/Membro del Consiglio | 17/11/2021 | - |
| Corporate Officer/Principal | 17/11/2021 | - |
Storia della carriera di Andrew Muratore
Statistiche
Distribuzione geografica
| Canada | 2 |
Posizioni
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- Andrew Muratore
- Esperienza
